Mawer Investment Management Ltd. boosted its stake in shares of CME Group Inc. (NASDAQ:CME) by 9.6% in the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 701,233 shares of the financial services provider’s stock after buying an additional 61,546 shares during the period. Mawer Investment Management Ltd. owned approximately 0.21% of CME Group worth $95,151,000 at the end of the most recent reporting period.
Other hedge funds also recently bought and sold shares of the company. ST Germain D J Co. Inc. bought a new stake in shares of CME Group in the 3rd quarter worth $232,000. Capital Advisors Inc. OK increased its holdings in shares of CME Group by 10.7% in the 2nd quarter. Capital Advisors Inc. OK now owns 84,533 shares of the financial services provider’s stock worth $10,587,000 after purchasing an additional 8,198 shares in the last quarter. Marvin & Palmer Associates Inc. increased its holdings in shares of CME Group by 100.7% in the 2nd quarter. Marvin & Palmer Associates Inc. now owns 57,278 shares of the financial services provider’s stock worth $7,173,000 after purchasing an additional 28,745 shares in the last quarter. Captrust Financial Advisors bought a new stake in shares of CME Group in the 2nd quarter worth $693,000. Finally, Commerce Bank increased its holdings in shares of CME Group by 3.8% in the 2nd quarter. Commerce Bank now owns 560,899 shares of the financial services provider’s stock worth $70,247,000 after purchasing an additional 20,449 shares in the last quarter. 82.58% of the stock is owned by institutional investors.
CME Group Inc. (NASDAQ:CME) traded up $2.41 during midday trading on Tuesday, reaching $141.90. The company had a trading volume of 1,138,000 shares, compared to its average volume of 1,356,536. The stock has a market capitalization of $47,650.00, a P/E ratio of 29.18, a PEG ratio of 2.86 and a beta of 0.71. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 0.11. CME Group Inc. has a 12 month low of $111.19 and a 12 month high of $142.64.
CME Group (NASDAQ:CME) last released its earnings results on Thursday, October 26th. The financial services provider reported $1.19 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.16 by $0.03. The company had revenue of $890.80 million for the quarter, compared to the consensus estimate of $890.22 million. CME Group had a return on equity of 7.89% and a net margin of 40.94%. CME Group’s quarterly revenue was up 5.8% compared to the same quarter last year. During the same period in the previous year, the business earned $1.05 earnings per share. sell-side analysts anticipate that CME Group Inc. will post 4.78 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Wednesday, December 27th. Investors of record on Friday, December 8th will be given a dividend of $0.66 per share. The ex-dividend date of this dividend is Thursday, December 7th. This represents a $2.64 annualized dividend and a yield of 1.86%. CME Group’s dividend payout ratio (DPR) is presently 59.86%.
Several analysts recently commented on CME shares. BidaskClub raised CME Group from a “hold” rating to a “buy” rating in a report on Wednesday, September 13th. UBS AG reaffirmed a “buy” rating and issued a $135.00 price objective (up previously from $134.00) on shares of CME Group in a report on Wednesday, September 6th. Royal Bank Of Canada set a $135.00 price objective on CME Group and gave the stock a “buy” rating in a report on Tuesday, August 1st. Citigroup Inc. lifted their price objective on CME Group from $138.00 to $155.00 and gave the stock a “buy” rating in a report on Thursday, October 19th. Finally, Keefe, Bruyette & Woods reaffirmed a “hold” rating and issued a $127.00 price objective on shares of CME Group in a report on Friday, August 18th. One analyst has rated the stock with a sell rating, four have given a hold rating and seven have issued a buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $141.75.
In other news, CFO John W. Pietrowicz sold 2,500 shares of the business’s stock in a transaction dated Wednesday, October 11th. The stock was sold at an average price of $136.83, for a total value of $342,075.00. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CFO John W. Pietrowicz sold 5,175 shares of the business’s stock in a transaction dated Thursday, November 2nd. The shares were sold at an average price of $139.70, for a total value of $722,947.50. The disclosure for this sale can be found here. Insiders have sold 13,939 shares of company stock worth $1,910,968 over the last quarter. 0.57% of the stock is owned by company insiders.
CME Group Company Profile
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME).
Receive News & Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related companies with MarketBeat.com's FREE daily email newsletter.